Supplemental material
Renal Failure
Volume 45, 2023 - Issue 1
Open access
1,275
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study
Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis
Yong Guoa Department of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China;b Clinical Research Center for Organ Transplantation in Hunan Province, Changsha, China;c Department of Organ Procurement Organization, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information
, Ling Lid Department of Urinary Surgery, The Second Xiangya Hospital of Central South University, Changsha, ChinaView further author information
& Shanbiao Hua Department of Kidney Transplantation, The Second Xiangya Hospital of Central South University, Changsha, China;b Clinical Research Center for Organ Transplantation in Hunan Province, Changsha, ChinaCorrespondence[email protected]
View further author information
View further author information
Article: 2179336
|
Received 12 Dec 2022, Accepted 07 Feb 2023, Published online: 03 Apr 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.